CarsonAllaria Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Hold
1,472
0.67% 26
2025
Q4
$1.58M Buy
1,472
+2
+0.1% +$1.91K 0.79% 26
2025
Q3
$1.12M Buy
1,470
+1
+0.1% +$744 0.58% 27
2025
Q2
$1.15M Sell
1,469
-4
-0.3% -$3.11K 0.61% 27
2025
Q1
$1.22M Sell
1,473
-3
-0.2% -$2.5K 0.71% 27
2024
Q4
$1.14M Sell
1,476
-121
-8% -$100K 0.65% 26
2024
Q3
$1.42M Buy
1,597
+2
+0.1% +$1.8K 0.81% 25
2024
Q2
$1.44M Sell
1,595
-38
-2% -$30.4K 0.88% 24
2024
Q1
$1.27M Buy
1,633
+3
+0.2% +$2.13K 0.8% 25
2023
Q4
$950K Sell
1,630
-18
-1% -$10.5K 0.68% 24
2023
Q3
$885K Hold
1,648
0.72% 25
2023
Q2
$773K Buy
1,648
+4
+0.2% +$1.68K 0.61% 25
2023
Q1
$565K Buy
1,644
+5
+0.3% +$1.69K 0.48% 29
2022
Q4
$600K Buy
1,639
+1,145
+232% +$406K 0.53% 28
2022
Q3
$160K Buy
494
+2
+0.4% +$634 0.15% 73
2022
Q2
$160K Hold
492
0.15% 75
2022
Q1
$141K Buy
492
+2
+0.4% +$515 0.13% 77
2021
Q4
$135K Buy
+490
New +$124K 0.12% 83

Other funds holding LLY

CarsonAllaria Wealth Management's LLY Position: Q1 2026 in Review

CarsonAllaria Wealth Management held its Eli Lilly (LLY) position steady in Q1 2026 at 1,472 shares worth $1.35M. The position accounts for 0.67% of the portfolio, ranked #26.

CarsonAllaria Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • CarsonAllaria Wealth Management held 1,472 shares of Eli Lilly worth $1.35M as of Q1 2026.
  • CarsonAllaria Wealth Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.67% of CarsonAllaria Wealth Management's portfolio in Q1 2026, its #26 holding.
  • CarsonAllaria Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • CarsonAllaria Wealth Management's Eli Lilly position peaked at $1.58M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CarsonAllaria Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.